Home
Clinical Trials
Search
Office Tools
Priority Diagrams
Ambulatory Care
Tissue Consent
Web
Site
Search
Friday, July 03, 2009
..::
Clinical Trials
::..
Register
Login
Clinical Trials
View All Recent Entries
All Programs
BMT
Breast
Cutaneous
Gastrointestinal
Genitourinary
Gynecologic Oncology
Head & Neck
Malignant Hematology
Neuro-Oncology
Pediatric
Prevention Control
Sarcoma
Thoracic
Search Trials
All
All Programs
BMT
Breast
Cutaneous
Gastrointestinal
Genitourinary
Gynecologic Oncology
Head & Neck
Malignant Hematology
Neuro-Oncology
Pediatric
Prevention Control
Sarcoma
Thoracic
Keywords
Phrase
Archives
Study Number:
Search
Neuro-Oncology
Category:
Neuro-Oncology
Created:
1/2/2007 11:40 AM
Neuro-Oncology
Brain (101066)
Sponsor: MD Anderson/Schering Plough (MDACC 2004-0662)
By Neuro-Oncology on
7/2/2009 4:00 AM
Randomized, Factorial Design, Phase II Trial of Temozolomide Alone and in Combination with Possible Permutations of Thalidomide, Isotretinoin, and/or Celecoxib as Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme.
HIPAA Authorization
Informed Consent
Protocol
More...
Brain (101247)
Sponsor: RTOG (0614)
By Neuro-Oncology on
7/2/2009 4:00 AM
A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy.
HIPAA Authorization
HIPAA Authorization - VA
Informed Consent
Informed Consent - VA
Protocol
More...
Brain (101248)
Sponsor: Boehringer Ingelheim Pharm (1200.36)
By Neuro-Oncology on
7/2/2009 4:00 AM
BIBW 2992 With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
Protocol
More...
Copyright 2007 by Hollings Cancer Center
Terms Of Use
Privacy Statement